We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
iShares MSCI Japan ETF
EWJ
$21.7B
| $478K | ﹤0.01% |
+7,000
| New | +$478K |
|
|
RMGCW
1952
CALL
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
| $477K | ﹤0.01% |
48,625
| – | – |
|
1953
Madrigal Pharmaceuticals
MDGL
$12.7B
| $476K | ﹤0.01% |
+1,700
| New | +$405K |
|
1954
Crexendo
CXDO
$224M
| $475K | ﹤0.01% |
150,723
+50,148
| +50% | +$195K |
|
1955
Alvotech
ALVO
$1.04B
| $474K | ﹤0.01% |
38,992
-211,131
| -84% | -$2.82M |
|
1956
iShares Asia 50 ETF
AIA
$4.51B
| $474K | ﹤0.01% |
7,060
+2,860
| +68% | +$184K |
|
1957
Enel Chile
ENIC
$6.05B
| $474K | ﹤0.01% |
+169,120
| New | +$500K |
|
|
MPT
1958
Medical Properties Trust
MPT
$2.86B
| $472K | ﹤0.01% |
109,600
-1,350,300
| -92% | -$6.47M |
|
1959
UNIFI
UFI
$121M
| $472K | ﹤0.01% |
80,172
+7,679
| +11% | +$45.7K |
|
1960
Relmada Therapeutics
RLMD
$546M
| $470K | ﹤0.01% |
156,619
-51,251
| -25% | -$185K |
|
1961
Dell
DELL
$276B
| $470K | ﹤0.01% |
+3,406
| New | +$457K |
|
|
NWLI
1962
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $467K | ﹤0.01% |
939
-61
| -6% | -$29.9K |
|
1963
SPS Commerce
SPSC
$2.41B
| $466K | ﹤0.01% |
2,475
-10,240
| -81% | -$1.87M |
|
|
HLLY.WS
1964
CALL
DELISTED
Holley Inc Warrants
HLLY.WS
| $465K | ﹤0.01% |
130,000
-43,638
| -25% | -$8.31K |
|
1965
iRadimed
IRMD
$1.22B
| $463K | ﹤0.01% |
+10,531
| New | +$448K |
|
1966
Brown-Forman Class B
BF.B
$12.6B
| $459K | ﹤0.01% |
10,621
-103,500
| -91% | -$4.86M |
|
1967
OptimizeRx
OPRX
$120M
| $457K | ﹤0.01% |
+45,748
| New | +$503K |
|
1968
Regenxbio
RGNX
$622M
| $457K | ﹤0.01% |
+39,093
| New | +$608K |
|
1969
Woodside Energy
WDS
$41.4B
| $457K | ﹤0.01% |
24,308
-22,702
| -48% | -$422K |
|
|
DEC
1970
Diversified Energy Company
DEC
$878M
| $457K | ﹤0.01% |
33,889
-228,165
| -87% | -$3.17M |
|
1971
Fidelity MSCI Information Technology Index ETF
FTEC
$19.7B
| $456K | ﹤0.01% |
+2,660
| New | +$421K |
|
|
RERE
1972
ATRenew
RERE
$913M
| $455K | ﹤0.01% |
192,036
+134,151
| +232% | +$294K |
|
|
TSE
1973
DELISTED
Trinseo
TSE
| $455K | ﹤0.01% |
+197,020
| New | +$613K |
|
|
MTLS
1974
Materialise
MTLS
$373M
| $455K | ﹤0.01% |
90,759
-41,010
| -31% | -$211K |
|
1975
Flowers Foods
FLO
$1.62B
| $453K | ﹤0.01% |
+20,413
| New | +$483K |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.